Flu-like symptoms following botulinum toxin therapy.

作者: Jose F. Baizabal-Carvallo , Joseph Jankovic , Eric Pappert

DOI: 10.1016/J.TOXICON.2011.04.019

关键词: AntipyreticIn patientBotulinum toxinFlu-like symptomsUpper respiratory tract infectionClostridium botulinumMedicineSurgeryInternal medicineComplicationGeneral malaise

摘要: This paper reviews the relevant literature on flu-like symptoms (FLS) in patients treated with botulinum toxin (BoNT) type A and B. We conducted a systematic search PubMed Medline of publications BoNT FLS. FLS were defined as presence an upper respiratory tract infection associated fever, general malaise or fatigue, within one month after injections not secondary to any other identified condition. have been reported between 1.7 20% various preparations BoNT/A. Most mild moderate lasting less than 2 weeks, but 66 serious AEs related Food Drug Administration 1989 2003. No significant differences frequency emerged when different BoNT/A commercial products compared, although no well-designed head-to-head comparison trials focusing published. For BoNT/B preparations, 5-55% cases. concluded that varies widely studies clear risk factors for this complication. suggest potential treatments like analgesics/antipyretics switching antigenic case persistent symptoms.

参考文章(69)
M Behari, S Bhaumik, Botulinum toxin A--injection for cervical dystonia. Journal of Association of Physicians of India. ,vol. 47, pp. 267- 270 ,(1999)
Noah Scheinfeld, Joshua D Rosenberg, Jeffrey M Weinberg, Levamisole in Dermatology American Journal of Clinical Dermatology. ,vol. 5, pp. 97- 104 ,(2004) , 10.2165/00128071-200405020-00004
Mark Hallett, Joseph Jankovic, Therapy with botulinum toxin M. Dekker. ,(1994)
Leo Verhagen Metman, Encyclopedia of movement disorders Elsevier, Acad. Press. ,(2010)
U B Muthane, J N Panicker, Botulinum toxins: pharmacology and its current therapeutic evidence for use. Neurology India. ,vol. 51, pp. 455- 460 ,(2003)
Eric A. Johnson, Cesare Montecucco, Chapter 11 Botulism Handbook of Clinical Neurology. ,vol. 91, pp. 333- 368 ,(2008) , 10.1016/S0072-9752(07)01511-4
João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina Sampaio, Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews. ,vol. 12, pp. 0- 0 ,(2005) , 10.1002/14651858.CD003633.PUB3
D. Dressler, Botulinum toxin for treatment of dystonia European Journal of Neurology. ,vol. 17, pp. 88- 96 ,(2010) , 10.1111/J.1468-1331.2010.03058.X
Raquel E Marques, Gonçalo S Duarte, Filipe B Rodrigues, Mafalda Castelão, Joaquim Ferreira, Cristina Sampaio, A Peter Moore, João Costa, Botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews. ,(2016) , 10.1002/14651858.CD004315.PUB3
Leslie Baumann, Anele Slezinger, Monica Halem, Justin Vujevich, Karin Mallin, Carlos Charles, Lucy K. Martin, Laura Black, Joy Bryde, Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis. Dermatologic Surgery. ,vol. 31, pp. 263- 270 ,(2005) , 10.1111/J.1524-4725.2005.31071